These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 574040)

  • 1. The oral activity of delta'-tetrahydrocannabinol and its dependence on prostaglandin E2.
    Fairbairn JW; Pickens JT
    Br J Pharmacol; 1979 Nov; 67(3):379-85. PubMed ID: 574040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sedative activity of cannabis in relation to its delta'-trans-tetrahydrocannabinol and cannabidiol content.
    Pickens JT
    Br J Pharmacol; 1981 Apr; 72(4):649-56. PubMed ID: 6269680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of conditions influencing endogenous prostaglandins on the activity of delta'-tetrahydrocannabinol in mice.
    Fairbairn JW; Pickens JT
    Br J Pharmacol; 1980 Jul; 69(3):491-3. PubMed ID: 6249435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of cannabis in relation to its delta'-trans-tetrahydro-cannabinol content.
    Fairbairn JW; Pickens JT
    Br J Pharmacol; 1981 Mar; 72(3):401-9. PubMed ID: 6266564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A major metabolite of delta 1-tetrahydrocannabinol reduces its cataleptic effect in mice.
    Burstein S; Hunter SA; Latham V; Renzulli L
    Experientia; 1987 Apr; 43(4):402-3. PubMed ID: 3032669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-tolerance to the hypothermic effect of delta 8-tetrahydrocannabinol 11-hydroxy-delta 8-tetrahydrocannabinol and chlorpromazine in the mouse.
    Yamamoto I; Watanabe K; Narimatsu S; Hamajima K; Yoshimura H
    Eur J Pharmacol; 1985 May; 111(2):159-66. PubMed ID: 2990949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the hypothermic response of mice to delta-9-tetrahydrocannabinol by subhypothermic doses of chlorpromazine and phentolamine.
    Gray GA; Hedley D; Pertwee RG
    Neuropharmacology; 1987; 26(2-3):229-35. PubMed ID: 3035414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions among the cannabinoids in the antagonism of the abdominal constriction response in the mouse.
    Sanders J; Jackson DM; Starmer GA
    Psychopharmacology (Berl); 1979 Mar; 61(3):281-5. PubMed ID: 156380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol.
    Hollister LE; Gillespie H
    Clin Pharmacol Ther; 1975 Jul; 18(1):80-3. PubMed ID: 1097148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. delta-9-tetrahydrocannabinol (THC) increases brain prostaglandins in the rat.
    Bhattacharya SK
    Psychopharmacology (Berl); 1986; 90(4):499-502. PubMed ID: 3027735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration in the level of endogenous hypothalamic prostaglandins induced by delta 9-tetrahydrocannabinol in the rat.
    Coupar IM; Taylor DA
    Br J Pharmacol; 1982 May; 76(1):115-9. PubMed ID: 6282371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of vasopressin V1a receptor in ∆
    Egashira N; Koushi E; Myose T; Tanoue A; Mishima K; Tsuchihashi R; Kinjo J; Tanaka H; Morimoto S; Iwasaki K
    Psychopharmacology (Berl); 2017 Dec; 234(23-24):3475-3483. PubMed ID: 28905207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and brain levels of delta 6-THC and seven monooxygenated metabolites correlated to the cataleptic effect in the mouse.
    Ohlsson A; Widman M; Carlsson S; Ryman T; Strid C
    Acta Pharmacol Toxicol (Copenh); 1980 Oct; 47(4):308-17. PubMed ID: 6258385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization against prostaglandins reduces delta 1-tetrahydrocannabinol-induced catalepsy in mice.
    Burstein SH; Hull K; Hunter SA; Shilstone J
    Mol Pharmacol; 1989 Jan; 35(1):6-9. PubMed ID: 2536469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of brain prostaglandin E2 levels in rodents by delta 1-tetrahydrocannabinol.
    Hunter SA; Audette CA; Burstein S
    Prostaglandins Leukot Essent Fatty Acids; 1991 Jul; 43(3):185-90. PubMed ID: 1651514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between THC and cannabidiol in mouse models of cannabinoid activity.
    Varvel SA; Wiley JL; Yang R; Bridgen DT; Long K; Lichtman AH; Martin BR
    Psychopharmacology (Berl); 2006 Jun; 186(2):226-34. PubMed ID: 16572263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ring test: a quantitative method for assessing the 'cataleptic' effect of cannabis in mice.
    Pertwee RG
    Br J Pharmacol; 1972 Dec; 46(4):753-63. PubMed ID: 4655271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
    Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between cannabidiol and Δ
    Todd SM; Zhou C; Clarke DJ; Chohan TW; Bahceci D; Arnold JC
    Eur Neuropsychopharmacol; 2017 Feb; 27(2):132-145. PubMed ID: 28043732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
    Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.